A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm	Recruiting	Phase 2	2026-10-09		NCT07644559

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Verastem, Inc.	24

31 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Calvary Mater Newcastle	Waratah	Australia	49
Cedars-Sinai Medical Center	Los Angeles	United States	392
Dana-Farber Cancer Institute	Boston	United States	626
ICON Cancer Centre	South Brisbane	Australia	1
ICON Kurralta Park	Kurralta Park	Australia	1
Johns Hopkins University	Baltimore	United States	150
Macquarie University Hospital	Sydney	Australia	1
Massachusetts General Hospital	Boston	United States	1015
Mayo Clinical Florida	Jacksonville	United States	1
Mayo Clinical Rochester	Rochester	United States	1
MD Anderson Cancer Center	Houston	United States	5
Moffitt Cancer Center	Tampa	United States	523
NYU-Manhattan	New York	United States	1
Princess Margaret Cancer Center	Toronto	Canada	30
Sarah Cannon Research Institute	Nashville	United States	119
START Dallas	Fort Worth	United States	4
START Midwest	Grand Rapids	United States	79
START New Jersey	East Brunswick	United States	16
START- Los Angeles	Los Angeles	United States	1
START- Mountain Region	West Valley City	United States	1
START- San Antonio	San Antonio	United States	4
Sunnybrook Health Sciences Centre	Toronto	Canada	167
University of Chicago	Chicago	United States	312
University of Michigan	Ann Arbor	United States	538
University of North Carolina	Chapel Hill	United States	101

Clinical trials